Click for best price
Pituitary Cancer Market Size, Share 2022
Pituitary adenomas are tumors that occur in the pituitary gland. Pituitary adenomas are generally divided into three categories dependent upon their biological functioning: benign adenoma, invasive adenoma, and carcinomas. Most adenomas are benign, approximately 35% are invasive and just 0.1% to 0.2% are carcinomas. Pituitary adenomas represent from 10% to 25% of all intracranial neoplasms and the estimated prevalence rate in the general population is approximately 17%.
This report contains market size and forecasts of Pituitary Cancer in Global, including the following market information:
Global top five companies in 2021 (%)
The global Pituitary Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Blood Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pituitary Cancer include Trinity Biotech, Salzman, Genentech, Sigma-Aldrich, Varian Medical Systems, Elekta, Accuray Incorporated, Ion Beam Applications and Nordion, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pituitary Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pituitary Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pituitary Cancer Market Segment Percentages, by Type, 2021 (%)
- Blood Tests
- Urine Test
- Brain Imaging
- Vision Testing
Global Pituitary Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pituitary Cancer Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Clinics
- Diagnostic Centers
- Research Institutes
Global Pituitary Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pituitary Cancer Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Pituitary Cancer revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Pituitary Cancer revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Trinity Biotech
- Salzman
- Genentech
- Sigma-Aldrich
- Varian Medical Systems
- Elekta
- Accuray Incorporated
- Ion Beam Applications
- Nordion
- Becton Dickinson
- Isoray Medical
- RaySearch Laboratories
- Mevion Medical Systems
| Report Attributes |
Report Details |
| Report Title |
Pituitary Cancer Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pituitary Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pituitary Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pituitary Cancer Overall Market Size
2.1 Global Pituitary Cancer Market Size: 2021 VS 2028
2.2 Global Pituitary Cancer Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pituitary Cancer Players in Global Market
3.2 Top Global Pituitary Cancer Companies Ranked by Revenue
3.3 Global Pituitary Cancer Revenue by Companies
3.4 Top 3 and Top 5 Pituitary Cancer Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pituitary Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pituitary Cancer Players in Global Market
3.6.1 List of Global Tier 1 Pituitary Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Pituitary Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Pituitary Cancer Market Size Markets, 2021 & 2028
4.1.2 Blood Tests
4.1.3 Urine Test
4.1.4 Brain Imaging
4.1.5 Vision Testing
4.2 By Type - Global Pituitary Cancer Revenue & Forecasts
4.2.1 By Type - Global Pituitary Cancer Revenue, 2017-2022
4.2.2 By Type - Global Pituitary Cancer Revenue, 2023-2028
4.2.3 By Type - Global Pituitary Cancer Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pituitary Cancer Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Diagnostic Centers
5.1.5 Research Institutes
5.2 By Application - Global Pituitary Cancer Revenue & Forecasts
5.2.1 By Application - Global Pituitary Cancer Revenue, 2017-2022
5.2.2 By Application - Global Pituitary Cancer Revenue, 2023-2028
5.2.3 By Application - Global Pituitary Cancer Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Pituitary Cancer Market Size, 2021 & 2028
6.2 By Region - Global Pituitary Cancer Revenue & Forecasts
6.2.1 By Region - Global Pituitary Cancer Revenue, 2017-2022
6.2.2 By Region - Global Pituitary Cancer Revenue, 2023-2028
6.2.3 By Region - Global Pituitary Cancer Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pituitary Cancer Revenue, 2017-2028
6.3.2 US Pituitary Cancer Market Size, 2017-2028
6.3.3 Canada Pituitary Cancer Market Size, 2017-2028
6.3.4 Mexico Pituitary Cancer Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pituitary Cancer Revenue, 2017-2028
6.4.2 Germany Pituitary Cancer Market Size, 2017-2028
6.4.3 France Pituitary Cancer Market Size, 2017-2028
6.4.4 U.K. Pituitary Cancer Market Size, 2017-2028
6.4.5 Italy Pituitary Cancer Market Size, 2017-2028
6.4.6 Russia Pituitary Cancer Market Size, 2017-2028
6.4.7 Nordic Countries Pituitary Cancer Market Size, 2017-2028
6.4.8 Benelux Pituitary Cancer Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pituitary Cancer Revenue, 2017-2028
6.5.2 China Pituitary Cancer Market Size, 2017-2028
6.5.3 Japan Pituitary Cancer Market Size, 2017-2028
6.5.4 South Korea Pituitary Cancer Market Size, 2017-2028
6.5.5 Southeast Asia Pituitary Cancer Market Size, 2017-2028
6.5.6 India Pituitary Cancer Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pituitary Cancer Revenue, 2017-2028
6.6.2 Brazil Pituitary Cancer Market Size, 2017-2028
6.6.3 Argentina Pituitary Cancer Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pituitary Cancer Revenue, 2017-2028
6.7.2 Turkey Pituitary Cancer Market Size, 2017-2028
6.7.3 Israel Pituitary Cancer Market Size, 2017-2028
6.7.4 Saudi Arabia Pituitary Cancer Market Size, 2017-2028
6.7.5 UAE Pituitary Cancer Market Size, 2017-2028
7 Players Profiles
7.1 Trinity Biotech
7.1.1 Trinity Biotech Corporate Summary
7.1.2 Trinity Biotech Business Overview
7.1.3 Trinity Biotech Pituitary Cancer Major Product Offerings
7.1.4 Trinity Biotech Pituitary Cancer Revenue in Global Market (2017-2022)
7.1.5 Trinity Biotech Key News
7.2 Salzman
7.2.1 Salzman Corporate Summary
7.2.2 Salzman Business Overview
7.2.3 Salzman Pituitary Cancer Major Product Offerings
7.2.4 Salzman Pituitary Cancer Revenue in Global Market (2017-2022)
7.2.5 Salzman Key News
7.3 Genentech
7.3.1 Genentech Corporate Summary
7.3.2 Genentech Business Overview
7.3.3 Genentech Pituitary Cancer Major Product Offerings
7.3.4 Genentech Pituitary Cancer Revenue in Global Market (2017-2022)
7.3.5 Genentech Key News
7.4 Sigma-Aldrich
7.4.1 Sigma-Aldrich Corporate Summary
7.4.2 Sigma-Aldrich Business Overview
7.4.3 Sigma-Aldrich Pituitary Cancer Major Product Offerings
7.4.4 Sigma-Aldrich Pituitary Cancer Revenue in Global Market (2017-2022)
7.4.5 Sigma-Aldrich Key News
7.5 Varian Medical Systems
7.5.1 Varian Medical Systems Corporate Summary
7.5.2 Varian Medical Systems Business Overview
7.5.3 Varian Medical Systems Pituitary Cancer Major Product Offerings
7.5.4 Varian Medical Systems Pituitary Cancer Revenue in Global Market (2017-2022)
7.5.5 Varian Medical Systems Key News
7.6 Elekta
7.6.1 Elekta Corporate Summary
7.6.2 Elekta Business Overview
7.6.3 Elekta Pituitary Cancer Major Product Offerings
7.6.4 Elekta Pituitary Cancer Revenue in Global Market (2017-2022)
7.6.5 Elekta Key News
7.7 Accuray Incorporated
7.7.1 Accuray Incorporated Corporate Summary
7.7.2 Accuray Incorporated Business Overview
7.7.3 Accuray Incorporated Pituitary Cancer Major Product Offerings
7.7.4 Accuray Incorporated Pituitary Cancer Revenue in Global Market (2017-2022)
7.7.5 Accuray Incorporated Key News
7.8 Ion Beam Applications
7.8.1 Ion Beam Applications Corporate Summary
7.8.2 Ion Beam Applications Business Overview
7.8.3 Ion Beam Applications Pituitary Cancer Major Product Offerings
7.8.4 Ion Beam Applications Pituitary Cancer Revenue in Global Market (2017-2022)
7.8.5 Ion Beam Applications Key News
7.9 Nordion
7.9.1 Nordion Corporate Summary
7.9.2 Nordion Business Overview
7.9.3 Nordion Pituitary Cancer Major Product Offerings
7.9.4 Nordion Pituitary Cancer Revenue in Global Market (2017-2022)
7.9.5 Nordion Key News
7.10 Becton Dickinson
7.10.1 Becton Dickinson Corporate Summary
7.10.2 Becton Dickinson Business Overview
7.10.3 Becton Dickinson Pituitary Cancer Major Product Offerings
7.10.4 Becton Dickinson Pituitary Cancer Revenue in Global Market (2017-2022)
7.10.5 Becton Dickinson Key News
7.11 Isoray Medical
7.11.1 Isoray Medical Corporate Summary
7.11.2 Isoray Medical Business Overview
7.11.3 Isoray Medical Pituitary Cancer Major Product Offerings
7.11.4 Isoray Medical Pituitary Cancer Revenue in Global Market (2017-2022)
7.11.5 Isoray Medical Key News
7.12 RaySearch Laboratories
7.12.1 RaySearch Laboratories Corporate Summary
7.12.2 RaySearch Laboratories Business Overview
7.12.3 RaySearch Laboratories Pituitary Cancer Major Product Offerings
7.12.4 RaySearch Laboratories Pituitary Cancer Revenue in Global Market (2017-2022)
7.12.5 RaySearch Laboratories Key News
7.13 Mevion Medical Systems
7.13.1 Mevion Medical Systems Corporate Summary
7.13.2 Mevion Medical Systems Business Overview
7.13.3 Mevion Medical Systems Pituitary Cancer Major Product Offerings
7.13.4 Mevion Medical Systems Pituitary Cancer Revenue in Global Market (2017-2022)
7.13.5 Mevion Medical Systems Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pituitary Cancer Market Opportunities & Trends in Global Market
Table 2. Pituitary Cancer Market Drivers in Global Market
Table 3. Pituitary Cancer Market Restraints in Global Market
Table 4. Key Players of Pituitary Cancer in Global Market
Table 5. Top Pituitary Cancer Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pituitary Cancer Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pituitary Cancer Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pituitary Cancer Product Type
Table 9. List of Global Tier 1 Pituitary Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pituitary Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Pituitary Cancer Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pituitary Cancer Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pituitary Cancer Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Pituitary Cancer Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pituitary Cancer Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pituitary Cancer Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Pituitary Cancer Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pituitary Cancer Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pituitary Cancer Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pituitary Cancer Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pituitary Cancer Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pituitary Cancer Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pituitary Cancer Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pituitary Cancer Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pituitary Cancer Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pituitary Cancer Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pituitary Cancer Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pituitary Cancer Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pituitary Cancer Revenue, (US$, Mn), 2023-2028
Table 30. Trinity Biotech Corporate Summary
Table 31. Trinity Biotech Pituitary Cancer Product Offerings
Table 32. Trinity Biotech Pituitary Cancer Revenue (US$, Mn), (2017-2022)
Table 33. Salzman Corporate Summary
Table 34. Salzman Pituitary Cancer Product Offerings
Table 35. Salzman Pituitary Cancer Revenue (US$, Mn), (2017-2022)
Table 36. Genentech Corporate Summary
Table 37. Genentech Pituitary Cancer Product Offerings
Table 38. Genentech Pituitary Cancer Revenue (US$, Mn), (2017-2022)
Table 39. Sigma-Aldrich Corporate Summary
Table 40. Sigma-Aldrich Pituitary Cancer Product Offerings
Table 41. Sigma-Aldrich Pituitary Cancer Revenue (US$, Mn), (2017-2022)
Table 42. Varian Medical Systems Corporate Summary
Table 43. Varian Medical Systems Pituitary Cancer Product Offerings
Table 44. Varian Medical Systems Pituitary Cancer Revenue (US$, Mn), (2017-2022)
Table 45. Elekta Corporate Summary
Table 46. Elekta Pituitary Cancer Product Offerings
Table 47. Elekta Pituitary Cancer Revenue (US$, Mn), (2017-2022)
Table 48. Accuray Incorporated Corporate Summary
Table 49. Accuray Incorporated Pituitary Cancer Product Offerings
Table 50. Accuray Incorporated Pituitary Cancer Revenue (US$, Mn), (2017-2022)
Table 51. Ion Beam Applications Corporate Summary
Table 52. Ion Beam Applications Pituitary Cancer Product Offerings
Table 53. Ion Beam Applications Pituitary Cancer Revenue (US$, Mn), (2017-2022)
Table 54. Nordion Corporate Summary
Table 55. Nordion Pituitary Cancer Product Offerings
Table 56. Nordion Pituitary Cancer Revenue (US$, Mn), (2017-2022)
Table 57. Becton Dickinson Corporate Summary
Table 58. Becton Dickinson Pituitary Cancer Product Offerings
Table 59. Becton Dickinson Pituitary Cancer Revenue (US$, Mn), (2017-2022)
Table 60. Isoray Medical Corporate Summary
Table 61. Isoray Medical Pituitary Cancer Product Offerings
Table 62. Isoray Medical Pituitary Cancer Revenue (US$, Mn), (2017-2022)
Table 63. RaySearch Laboratories Corporate Summary
Table 64. RaySearch Laboratories Pituitary Cancer Product Offerings
Table 65. RaySearch Laboratories Pituitary Cancer Revenue (US$, Mn), (2017-2022)
Table 66. Mevion Medical Systems Corporate Summary
Table 67. Mevion Medical Systems Pituitary Cancer Product Offerings
Table 68. Mevion Medical Systems Pituitary Cancer Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Pituitary Cancer Segment by Type in 2021
Figure 2. Pituitary Cancer Segment by Application in 2021
Figure 3. Global Pituitary Cancer Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pituitary Cancer Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pituitary Cancer Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pituitary Cancer Revenue in 2021
Figure 8. By Type - Global Pituitary Cancer Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pituitary Cancer Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pituitary Cancer Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pituitary Cancer Revenue Market Share, 2017-2028
Figure 12. US Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pituitary Cancer Revenue Market Share, 2017-2028
Figure 16. Germany Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 17. France Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pituitary Cancer Revenue Market Share, 2017-2028
Figure 24. China Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 28. India Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pituitary Cancer Revenue Market Share, 2017-2028
Figure 30. Brazil Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pituitary Cancer Revenue Market Share, 2017-2028
Figure 33. Turkey Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pituitary Cancer Revenue, (US$, Mn), 2017-2028
Figure 37. Trinity Biotech Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Salzman Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Genentech Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sigma-Aldrich Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Varian Medical Systems Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Elekta Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Accuray Incorporated Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Ion Beam Applications Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Nordion Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Becton Dickinson Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Isoray Medical Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. RaySearch Laboratories Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Mevion Medical Systems Pituitary Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
